Related Experiment Video
Updated: Mar 30, 2026

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Complete Genome Sequence of Enterococcus Bacteriophage EFLK1
Leron Khalifa1, Shunit Coppenhagen-Glazer2, Mor Shlezinger1
1Faculty of Dental Sciences, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel Department of Prosthodontics, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel.
A new bacteriophage, EFLK1, effectively targets enterococci strains resistant to the therapeutic phage EFDG1. This discovery offers a potential solution for overcoming phage resistance in enterococcal infections.
Area of Science:
- Microbiology
- Bacteriophage Therapy
- Genomics
Background:
- Enterococci are significant human pathogens.
- Therapeutic bacteriophage EFDG1 is effective against enterococci.
- Emergence of EFDG1-resistant enterococcal strains (EFDG1(r)) necessitates alternative treatments.
Purpose of the Study:
- To isolate and characterize a novel bacteriophage capable of targeting EFDG1-resistant enterococci.
- To provide a new therapeutic option against challenging enterococcal infections.
Main Methods:
- Isolation and characterization of a novel bacteriophage, EFLK1.
- Genomic sequencing and analysis of EFLK1.
- Evaluation of EFLK1's efficacy against EFDG1(r) strains.
Main Results:
- EFLK1 was successfully isolated and demonstrated high efficacy against EFDG1(r) strains.
- The complete genome of EFLK1 was sequenced and analyzed.
- Genomic data for EFLK1 was deposited in GenBank for future research.
Conclusions:
- EFLK1 represents a promising bacteriophage for combating EFDG1-resistant enterococci.
- This finding contributes to the development of phage therapy strategies against resistant bacterial pathogens.
Related Concept Videos
Viral Replication: Lytic Cycle
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle

